1
|
Targeting Ferroptosis: Pathological Mechanism and Treatment of Ischemia-Reperfusion Injury. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY 2021; 2021:1587922. [PMID: 34745412 PMCID: PMC8568519 DOI: 10.1155/2021/1587922] [Citation(s) in RCA: 70] [Impact Index Per Article: 23.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/30/2021] [Accepted: 09/13/2021] [Indexed: 01/01/2023]
Abstract
Ischemia-reperfusion (I/R) is a pathological process that occurs in many organs and diseases. Reperfusion, recovery of blood flow, and reoxygenation often lead to reperfusion injury. Drug therapy and early reperfusion therapy can reduce tissue injury and cell necrosis caused by ischemia, leading to irreversible I/R injury. Ferroptosis was clearly defined in 2012 as a newly discovered iron-dependent, peroxide-driven, nonapoptotic form of regulated cell death. Ferroptosis is considered the cause of reperfusion injury. This discovery provides new avenues for the recognition and treatment of diseases. Ferroptosis is a key factor that leads to I/R injury and organ failure. Given the important role of ferroptosis in I/R injury, there is considerable interest in the potential role of ferroptosis as a targeted treatment for a wide range of I/R injury-related diseases. Recently, substantial progress has been made in applying ferroptosis to I/R injury in various organs and diseases. The development of ferroptosis regulators is expected to provide new opportunities for the treatment of I/R injury. Herein, we analytically review the pathological mechanism and targeted treatment of ferroptosis in I/R and related diseases from the perspectives of myocardial I/R injury, cerebral I/R injury, and ischemic renal injury.
Collapse
|
2
|
Abstract
Ischemia/reperfusion (I/R) is a pathological process that occurs in numerous organs throughout the human body, and it is frequently associated with severe cellular damage and death. Recently it has emerged that ferroptosis, a new form of regulated cell death that is caused by iron-dependent lipid peroxidation, plays a significantly detrimental role in many I/R models. In this review, we aim to revise the pathological process of I/R and then explore the molecular pathogenesis of ferroptosis. Furthermore, we aim to evaluate the role that ferroptosis plays in I/R, providing evidence to support the targeting of ferroptosis in the I/R pathway may present as a therapeutic intervention to alleviate ischemia/reperfusion injury (IRI) associated cell damage and death.
Collapse
Affiliation(s)
- Hong-Fa Yan
- Department of Neurology and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, and Collaborative Center for Biotherapy, Chengdu, Sichuan 610041, China
| | - Qing-Zhang Tuo
- Department of Neurology and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, and Collaborative Center for Biotherapy, Chengdu, Sichuan 610041, China
| | - Qiao-Zhi Yin
- Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610041, China. E-mail:
| | - Peng Lei
- Department of Neurology and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, and Collaborative Center for Biotherapy, Chengdu, Sichuan 610041, China. E-mail:
| |
Collapse
|
3
|
Chatterjee M. Platelet lipidome: Dismantling the "Trojan horse" in the bloodstream. J Thromb Haemost 2020; 18:543-557. [PMID: 31868994 DOI: 10.1111/jth.14721] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2019] [Revised: 11/28/2019] [Accepted: 12/16/2019] [Indexed: 02/06/2023]
Abstract
The platelet-lipid chapter in the story of atherothrombosis is an old one, recapitulated and revised in many contexts. For decades several stimulating facets have been added to it, both unraveling and increasing the perplexity of platelet-lipid interplay and its pathophysiological consequences. The recent paradigm shift in our perspective has evolved with lipidomic analysis of the intraplatelet compartment and platelet releasate. These investigations have disclosed that platelets are in constant interaction with circulatory lipids, often reflected in their lipid repertoire. In addition, they offer a shielded intracellular space for oxidative lipid metabolism generating "toxic" metabolites that escape degradation by plasma lipases and antioxidant defense, circulate undetected by conventional plasma lipid profile, and deposited at atherosclerotic lesions or thrombus. Lipidomics divulges this silent invader in platelet vehicles, thereby providing potential biomarkers of pathologic manifestations and therapeutic targets to be exploited, which is surmised in this review.
Collapse
Affiliation(s)
- Madhumita Chatterjee
- Department of Cardiology and Angiology, Internal Medicine III, University Clinic Tübingen, Tübingen, Germany
| |
Collapse
|
5
|
Jouvène C, Fourmaux B, Géloën A, Balas L, Durand T, Lagarde M, Létisse M, Guichardant M. Ultra-Performance Liquid Chromatography-Mass Spectrometry Analysis of Free and Esterified Oxygenated Derivatives from Docosahexaenoic Acid in Rat Brain. Lipids 2018; 53:103-116. [PMID: 29469960 DOI: 10.1002/lipd.12006] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2017] [Revised: 10/04/2017] [Accepted: 10/18/2017] [Indexed: 12/21/2022]
Abstract
Docosahexaenoic acid (DHA), a prominent long-chain fatty acid of the omega-3 family, is present at high amount in brain tissues, especially in membrane phospholipids. This polyunsaturated fatty acid is the precursor of various oxygenated lipid mediators involved in diverse physiological and pathophysiological processes. Characterization of DHA-oxygenated metabolites is therefore crucial for better understanding the biological roles of DHA. In this study, we identified and measured, by ultrahigh-performance liquid chromatography coupled with tandem mass spectrometry, a number of oxygenated products derived from DHA in exsanguinated and nonexsanguinated brains. These metabolites were found both in free form and esterified in phospholipids. Interestingly, both (R)- and (S)-monohydroxylated fatty acid stereoisomers were observed free and esterified in phospholipids. Monohydroxylated metabolites were the main derivatives; however, measurable amounts of dihydroxylated products such as protectin DX were detected. Moreover, exsanguination allowed discriminating brain oxygenated metabolites from those generated in blood. These results obtained in healthy rats allowed an overview on the brain oxygenated metabolism of DHA, which deserves further research in pathophysiological conditions, especially in neurodegenerative diseases.
Collapse
Affiliation(s)
- Charlotte Jouvène
- Univ-Lyon, CarMeN laboratory, (Inserm UMR 1060, Inra UMR 1397), Université Claude Bernard Lyon 1, INSA-Lyon, IMBL, 20 Av A. Einstein, F-69100, Villeurbanne, France
| | - Baptiste Fourmaux
- Univ-Lyon, CarMeN laboratory, (Inserm UMR 1060, Inra UMR 1397), Université Claude Bernard Lyon 1, INSA-Lyon, IMBL, 20 Av A. Einstein, F-69100, Villeurbanne, France
| | - Alain Géloën
- Univ-Lyon, CarMeN laboratory, (Inserm UMR 1060, Inra UMR 1397), Université Claude Bernard Lyon 1, INSA-Lyon, IMBL, 20 Av A. Einstein, F-69100, Villeurbanne, France
| | - Laurence Balas
- Univ-Montpellier, IBMM, ENSCM, UMR CNRS 5247, Fac Pharm, 15 Av Ch Flahault, F-34093, Montpellier, 05, France
| | - Thierry Durand
- Univ-Montpellier, IBMM, ENSCM, UMR CNRS 5247, Fac Pharm, 15 Av Ch Flahault, F-34093, Montpellier, 05, France
| | - Michel Lagarde
- Univ-Lyon, CarMeN laboratory, (Inserm UMR 1060, Inra UMR 1397), Université Claude Bernard Lyon 1, INSA-Lyon, IMBL, 20 Av A. Einstein, F-69100, Villeurbanne, France
| | - Marion Létisse
- Univ-Lyon, CarMeN laboratory, (Inserm UMR 1060, Inra UMR 1397), Université Claude Bernard Lyon 1, INSA-Lyon, IMBL, 20 Av A. Einstein, F-69100, Villeurbanne, France
| | - Michel Guichardant
- Univ-Lyon, CarMeN laboratory, (Inserm UMR 1060, Inra UMR 1397), Université Claude Bernard Lyon 1, INSA-Lyon, IMBL, 20 Av A. Einstein, F-69100, Villeurbanne, France
| |
Collapse
|